Autres langues Morinaga Milk Industry Co., Ltd.

Actions

2264

JP3926800008

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
3 105 ^JPY	+0,58%		+1,60%	+13,82%

09/02	Morinaga Milk Industry Co. révise ses prévisions de dividendes pour l'exercice financier se terminant le 31 mars 2024	CI
2023	Le probiotique Bifidobacterium B-3 de Morinaga Milk Industry Co. reçoit l'approbation de l'enregistrement individuel reconnu en Corée du Sud	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hundreds in northeast Japan get sick after drinking school lunch milk	26/04
Morinaga Milk Industry Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/02
Morinaga Milk Industry Relocates Headquarters to a Newer Building in Minato-ku, Tokyo	18/01
Morinaga Milk Industry Co., Ltd. Announces Change of Address	18/01
Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea	17/11
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium B-3 Receives Approval of Individual Recognized Registration in South Korea	17/11
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	01/11
Morinaga Milk Industry Co., Ltd.'s Equity Buyback announced on May 15, 2023, has closed with 1,856,400 shares, representing 4.14% for ¥9,999.53 million.	31/10/23
Morinaga Milk Industry Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	26/10/23
Morinaga Milk Industry Co., Ltd. Revises Earnings Guidance for the First Six Months Ended September 30, 2023 and for the Fiscal Year Ending March 31, 2024	26/10/23
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	02/10/23
Morinaga Milk recibe la aprobación de la ANVISA en Brasil, incluyendo la declaración de funcionalidad para la salud intestinal, para el probiótico bifidobacterium longum, subespecie longum BB536	08/09/23
Das Probiotikum Bifidobacterium longum subsp. longum BB536 von Morinaga Milk erhält die ANVISA-Zulassung mit dem Vermerk „Darmgesundheit“ in Brasilien	08/09/23
Morinaga Milk's Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	07/09/23
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium Longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	07/09/23
Morinaga Milk Industry Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2024	09/08/23
Morinaga Milk Industry Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/08/23
Morinaga Milk Industry Issues Restricted Stock Compensation	02/08/23
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	03/07/23
Morinaga Milk Industry Co., Ltd. completed the acquisition of 20% stake in Morinaga Le May Vietnam Joint Stock Company from Le Van May and Do Thanh Tuan.	31/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Morinaga Milk Industry Co., Ltd.

Actions

2264

JP3926800008

Autres langues

Filtres